Recruiting now
-
HDR Endorectal Brachytherapy With 3D-Printed Guidance and Local Shielding for Rectal Cancer Organ Preservation
Not phased · 50 people · 1 site in China · Recruiting now
-
FMT+ QL1706+Bevacizumab+ XELOX as First-line Treatment for Advanced MSS-type Colorectal Cancer With Liver Metastasis
Phase 2 · 30 people · 1 site in China · Recruiting now
-
Ivosidenib Plus mFOLFOXIRI and Celecoxib for BRAF-targeted Therapy-refractory BRAF V600E-mutant Colorectal Cancer Patients
Phase 2 · 45 people · 1 site in China · Recruiting now
-
Evaluating Novel Therapies in ctDNA Positive GI Cancers
Phase 3 · 20 people · 3 sites in United States · Recruiting now
-
Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial
Phase 2 · 20 people · 2 sites in United States · Recruiting now
-
Adjuvant FOLFIRI Based-chemotherapy After Resection of CLM Responding to Preoperative FOLFIRI
Phase 3 · randomised · 254 people · 1 site in France · Recruiting now